A signature technology from Angela Koehler is a low-cost screening tool for studying how transcription factors—proteins that regulate gene expression—interact with each other, and identifying compounds that modulate them. Beyond her lab, the platform contributes to translational work in her startup, Kronos Bio, which is now conducting clinical trials targeting MYC, a transcription factor whose dysregulation helps drive multiple cancers.